a client has been prescribed a first-generation anticonvulsant for the treatment of partial seizure disorder. upon visiting the clinic, she revealed to the health care professional that she has not been compliant with the medication because she has experienced uncomfortable cognitive side effects. after discussing this with the team, a decision was made to start the client on a second-generation anticonvulsant. what is the rationale behind this?